Accessibility Menu
Tyme Technologies logo

Tyme Technologies(NASDAQ) TYME

This security has been delisted. This page is retained for historical reference.

Tyme Technologies last closing stock price
MetricPriceDate
Last closeUSD 0.312022-09-16
Tyme Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+26.87%USD 0.242022-09-09
1 month-6.7%USD 0.332022-08-17
3 month+15.07%USD 0.272022-06-17
Year to date-48.48%USD 0.602021-12-31
1 year-70.13%USD 1.042021-09-16
3 year-80.58%USD 1.602019-09-17
5 year-95%USD 6.212017-09-15
Since inception-94.08%USD 5.252015-03-12

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

TYME Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-23.83%

Return on Capital

-31.84%

Return on Assets

-24.62%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$24.76M

EBITDA

-$20.00M

Operating Cash Flow

-$20.21M

Capital Expenditure

$0.00

Free Cash Flow

-$20.21M

Cash & ST Invst.

$77.11M

Total Debt

$26.49K

Tyme Technologies Performance Analysis

Tyme Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-03-31USD 0N/A
Tyme Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22021-09-30N/A
Q32021-12-31N/A
Q42022-03-31N/A
Q12022-06-30N/A
Tyme Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-03-31USD -0.14N/A
Tyme Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22021-09-306.1%
Q32021-12-314.0%
Q42022-03-31-23.2%
Q12022-06-301.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2023YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

13

N/A

Net Income

-$6.51M

-9.7%

EBITDA

-$5.43M

-5.1%

Quarterly Fundamentals

Name
Q1 2023YOY CHG

Total Cash

$77.11M

+6.2%

Total Debt

$26.49K

-61.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$26.49K

-29.8%

Return on Assets

-24.62%

N/A

Return on Invested Capital

-31.64%

N/A

Free Cash Flow

-$4.78M

+17.7%

Operating Cash Flow

-$4.78M

+17.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KRONKronos Bio, Inc.
$0.88+1.49%
SGTXSigilon Therapeutics, Inc.
$22.47-2.56%
ALVRAlloVir, Inc.
$9.81+4.14%
TCRRTCR2 Therapeutics Inc.
$1.48+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.68+0.01%
MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares
$35.48+0.01%
BMNRBitmine Immersion Technologies
$17.81+0.03%
SMCXTidal Trust II - Defiance Daily Target 2x Long Smci ETF
$9.47+0.47%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.